The clinical development of obinutuzumab for the treatment of follicular lymphoma

par Ma, Barbara, Ujjani, Chaitra
Publié dans Cancer Manag Res (2017)

Vaccinations in CLL: implications for COVID-19

par Shadman, Mazyar, Ujjani, Chaitra
Publié dans Blood (2021)

Current challenges in the management of follicular lymphoma

par Yazdy, Maryam Sarraf, Ujjani, Chaitra
Publié dans Int J Hematol Oncol (2017)

Primary effusion lymphoma: current perspectives

par Narkhede, Mayur, Arora, Shagun, Ujjani, Chaitra
Publié dans Onco Targets Ther (2018)

The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma

par Lai, Catherine, Kandahari, Adrese Michael, Ujjani, Chaitra
Publié dans Blood Lymphat Cancer (2019)

Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient

par Hill, Joshua A., Ujjani, Chaitra S., Greninger, Alexander L., Shadman, Mazyar, Gopal, Ajay K.
Publié dans Cancer Cell (2021)

Concurrent Diagnosis of Chronic Myeloid Leukemia and Follicular Lymphoma: An Unreported Presentation

par Starr, Amy G., Jonna, Sushma R., Chahine, Joeffrey J., Kallakury, Bhaskar V., Ujjani, Chaitra S.
Publié dans Case Rep Hematol (2018)

A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL

par Ujjani, Chaitra, Wang, Hongkun, Skarbnik, Alan, Trivedi, Neel, Ramzi, Pari, Khan, Nadia, Cheson, Bruce D.
Publié dans Blood Adv (2018)

Management of CLL patients early in the COVID‐19 pandemic: An international survey of CLL experts

par Koffman, Brian, Mato, Anthony, Byrd, John C., Danilov, Alexey, Hedrick, Brad, Ujjani, Chaitra, Roeker, Lindsey, Stephens, Deborah M., Davids, Matthew S., Pagel, John M., Shadman, Mazyar
Publié dans Am J Hematol (2020)

Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103

par Ujjani, Chaitra S., Jung, Sin-Ho, Pitcher, Brandelyn, Martin, Peter, Park, Steven I., Blum, Kristie A., Smith, Sonali M., Czuczman, Myron, Davids, Matthew S., Levine, Ellis, Lewis, Lionel D., Smith, Scott E., Bartlett, Nancy L., Leonard, John P., Cheson, Bruce D.
Publié dans Blood (2016)

Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle Strategy

par Percival, Mary-Elizabeth M., Lynch, Ryan C., Halpern, Anna B., Shadman, Mazyar, Cassaday, Ryan D., Ujjani, Chaitra, Shustov, Andrei, Tseng, Yolanda D., Liu, Catherine, Pergam, Steven, Libby, Edward N., Scott, Bart L., Smith, Stephen D., Green, Damian J., Gopal, Ajay K., Cowan, Andrew J.
Publié dans JCO Oncol Pract (2020)

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy

par Ujjani, Chaitra, Mato, Anthony, Hill, Brian T, Allan, John N, Lansigan, Frederick, Jacobs, Ryan, Skarbnik, Alan, Tuncer, Hande, Pagel, John, Brander, Danielle, Cheson, Bruce, Barr, Paul, Roeker, Lindsey E, Pu, Jeffrey, Shah, Nirav N, Goy, Andre, Schuster, Stephen J, Lamanna, Nicole, Sehgal, Alison, Tam, Constantine S, Shadman, Mazyar
Publié dans Blood Lymphat Cancer (2020)

Outcomes and Toxicities of Programmed Death‐1 (PD‐1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real‐World, Multicenter Retrospective Analysis

par Bair, Steven M., Strelec, Lauren E., Feldman, Tatyana A., Ahmed, Gulrayz, Armand, Philippe, Shah, Nirav N., Singavi, Arun N., Reddy, Nishitha, Khan, Nadia, Andreadis, Charalambos, Vu, Khoan, Huntington, Scott F., Giri, Smith, Ujjani, Chaitra, Howlett, Christina, Faheem, Malik, Youngman, Matthew R., Nasta, Sunita D., Landsburg, Daniel J., Schuster, Stephen J., Svoboda, Jakub
Publié dans Oncologist (2018)

Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy

par Chow, Victor A., Gopal, Ajay K., Maloney, David G., Turtle, Cameron J., Smith, Stephen D., Ujjani, Chaitra S., Shadman, Mazyar, Cassaday, Ryan D., Till, Brian G., Tseng, Yolanda D., Warren, Edus H., Shustov, Andrei R., Menon, Manoj P., Bhark, Sandra, Acharya, Utkarsh H., Mullane, Erin, Hannan, Lindsay M., Voutsinas, Jenna M., Gooley, Ted A., Lynch, Ryan C.
Publié dans Am J Hematol (2019)

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis

par Mato, Anthony R., Nabhan, Chadhi, Thompson, Meghan C., Lamanna, Nicole, Brander, Danielle M., Hill, Brian, Howlett, Christina, Skarbnik, Alan, Cheson, Bruce D., Zent, Clive, Pu, Jeffrey, Kiselev, Pavel, Goy, Andre, Claxton, David, Isaac, Krista, Kennard, Kaitlin H., Timlin, Colleen, Landsburg, Daniel, Winter, Allison, Nasta, Sunita D., Bachow, Spencer H., Schuster, Stephen J., Dorsey, Colleen, Svoboda, Jakub, Barr, Paul, Ujjani, Chaitra S.
Publié dans Haematologica (2018)

The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia

par Eyre, Toby A., Roeker, Lindsey E., Fox, Christopher P., Gohill, Satyen H., Walewska, Renata, Walter, Harriet S., Forconi, Francesco, Broom, Angus, Arumainathan, Arvind, Brander, Danielle M., Allan, John N., Schuster, Stephen J., Hill, Brian T., Lansigan, Frederick, Cheson, Bruce D., Lamanna, Nicole, Coombs, Catherine C., Barr, Paul M., Skarbnik, Alan P., Shadman, Mazyar, Ujjani, Chaitra S., Pearson, Laurie, Pagel, John M., Jacobs, Ryan, Mato, Anthony R.
Publié dans Br J Haematol (2019)

Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia

par Eyre, Toby A., Lamanna, Nicole, Roeker, Lindsey E., Ujjani, Chaitra S, Hill, Brian T., Barr, Paul M., Lansigan, Erick, Cheson, Bruce D., Yazdy, Maryam, Allan, John N., Rhodes, Joanna, Schuster, Stephen J., Nabhan, Chadi, Skarbnik, Alan, Leslie, Lorie, Islam, Prioty, Whitaker, Katherine, Coombs, Catherine C., Tuncer, Hande H., Pagel, John M., Jacobs, Ryan, Winter, Allison M., Bailey, Neil, Sitlinger, Andrea, Schuh, Anna H., Follows, George, Fox, Christopher P., Brander, Danielle M., Shadman, Mazyar, Mato, Anthony R.
Publié dans Haematologica (2020)

Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial

par Mato, Anthony R., Roeker, Lindsey E., Allan, John N., Pagel, John M., Brander, Danielle M., Hill, Brian T., Cheson, Bruce D., Furman, Richard R., Lamanna, Nicole, Tam, Constantine S., Handunnetti, Sasanka, Jacobs, Ryan, Lansigan, Frederick, Bhavsar, Erica, Barr, Paul M., Shadman, Mazyar, Skarbnik, Alan P., Goy, Andre, Beach, Douglas F., Svoboda, Jakub, Pu, Jeffrey J., Sehgal, Alison R., Zent, Clive S., Tuncer, Hande H., Schuster, Stephen J., Pickens, Peter V., Shah, Nirav N., Rhodes, Joanna, Ujjani, Chaitra S., Nabhan, Chadi
Publié dans Am J Hematol (2018)

Tumor lysis, adverse events, and dose adjustments in 297 venetoclax treated CLL in routine clinical practice

par Roeker, Lindsey E., Fox, Christopher P., Eyre, Toby A., Brander, Danielle M., Allan, John N., Schuster, Stephen J., Nabhan, Chadi, Hill, Brian T., Shah, Nirav N., Lansigan, Frederick, Yazdy, Maryam, Cheson, Bruce D., Lamanna, Nicole, Singavi, Arun K., Coombs, Catherine C., Barr, Paul M., Skarbnik, Alan P., Shadman, Mazyar, Ujjani, Chaitra S., Tuncer, Hande H., Winter, Allison M., Rhodes, Joanna, Dorsey, Colleen, Morse, Hannah, Kabel, Charlene, Pagel, John M., Williams, Annalynn M., Jacobs, Ryan, Goy, Andre, Muralikrishnan, Sivraj, Pearson, Laurie, Sitlinger, Andrea, Bailey, Neil, Schuh, Anna, Kirkwood, Amy A., Mato, Anthony R.
Publié dans Clin Cancer Res (2019)

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

par Mato, Anthony R., Roeker, Lindsey E., Eyre, Toby A., Nabhan, Chadi, Lamanna, Nicole, Hill, Brian T., Brander, Danielle M., Barr, Paul M., Lansigan, Frederick, Cheson, Bruce D., Singavi, Arun K., Yazdy, Maryam Sarraf, Shah, Nirav N., Allan, John N., Bhavsar, Erica B., Rhodes, Joanna, Kennard, Kaitlin, Schuster, Stephen J., Williams, AnnaLynn M., Skarbnik, Alan P., Goy, Andre H., Goodfriend, Julie M., Dorsey, Colleen, Coombs, Catherine C., Tuncer, Hande, Ujjani, Chaitra S., Jacobs, Ryan, Winter, Allison M., Pagel, John M., Bailey, Neil, Schuh, Anna, Shadman, Mazyar, Sitlinger, Andrea, Weissbrot, Hanna, Muralikrishnan, Sivraj, Zelenetz, Andrew, Kirkwood, Amy A., Fox, Christopher P.
Publié dans Blood Adv (2019)